1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for BIAF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2023. Start Trial.
Date Value
September 09, 2026 -90.59%
September 08, 2026 -91.90%
September 04, 2026 -85.81%
September 03, 2026 -88.50%
September 02, 2026 -90.85%
September 01, 2026 -93.95%
August 31, 2026 -95.81%
August 28, 2026 -95.57%
August 27, 2026 -95.47%
August 26, 2026 -95.52%
August 25, 2026 -95.37%
August 24, 2026 -94.90%
August 21, 2026 -94.65%
August 20, 2026 -94.65%
August 19, 2026 -94.90%
August 18, 2026 -93.56%
August 17, 2026 -94.39%
August 14, 2026 -94.75%
August 13, 2026 -95.44%
August 12, 2026 -94.25%
August 11, 2026 -94.19%
August 10, 2026 -94.33%
August 07, 2026 -93.93%
August 06, 2026 -93.91%
August 05, 2026 -94.07%
Date Value
August 04, 2026 -93.96%
August 03, 2026 -93.22%
July 31, 2026 -93.40%
July 30, 2026 -93.45%
July 29, 2026 -93.97%
July 28, 2026 -93.77%
July 27, 2026 -93.20%
July 24, 2026 -93.66%
July 23, 2026 -93.60%
July 22, 2026 -93.12%
July 21, 2026 -93.56%
July 20, 2026 -93.48%
July 17, 2026 -92.93%
July 16, 2026 -92.83%
July 15, 2026 -91.78%
July 14, 2026 -91.76%
July 13, 2026 -92.40%
July 10, 2026 -91.76%
July 09, 2026 -92.37%
July 08, 2026 -92.15%
July 07, 2026 -90.56%
July 06, 2026 -90.11%
July 02, 2026 -90.46%
July 01, 2026 -89.33%
June 30, 2026 -90.58%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Anika Therapeutics, Inc. 139.2%
Perspective Therapeutics, Inc. -11.28%
MiMedx Group, Inc. -34.27%
Veracyte, Inc. 37.11%
ABVC BioPharma, Inc. -65.05%